🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“If you don’t benefit from chemotherapy, you want to avoid it.” Our CEO Jan Witowski shared with Forbes' Alex Knapp how Ataraxis Breast enables providers to recommend more precise, effective treatments—helping patients avoid unnecessary chemotherapy—and more.

Ataraxis is growing! We're now hiring for commercial, technical, medical and ops roles:

Anyone looking for a full stack engineer position? jobs.ashbyhq.com/ataraxis-ai/78… This is a great job in a great startup. You need to be a highly skilled computer scientist, have passion for coding and be relentless in pursuit of success. Please pass it to whoever might be interested!

We are coming to NeurIPS! Joe Cappadona will present results of our novel approach to training foundation models for digital pathology. This research goes beyond simply scaling model/data size, and led us to develop Kestrel, the model behind Ataraxis Breast. Come see us!

We are at #SABCS24 next week: Jan Witowski will present results of the Ataraxis Breast validation study—first time in public. This 8161 patient study showed our AI predicts recurrence&survival in all breast cancer patients, and with ⬆️accuracy than SoC genomic test. Come meet us

Yesterday, Jan Witowski presented the results of our 8,161-patient validation study of Ataraxis Breast at San Antonio Breast Cancer Symposium #SABCS24. Great turnout for results showing Ataraxis AI-native tests outperform genomic assays and work in all breast cancer subtypes.

Our team, including our CEO Jan Witowski, will be attending the 2025 J.P. Morgan Healthcare Conference #JPM2025 discussing our AI-native tools for treatment selection. Contact us to schedule a meeting: ataraxis.ai/contact-us

We are hiring for multiple engineering & research roles at Ataraxis AI! We recently raised a $20.4m Series A from top investors (AIX Ventures, Peter Thiel) and are quickly growing to help millions of cancer patients worldwide. Apply now at: jobs.ashbyhq.com/ataraxis-ai

We are at #ASCO25 this weekend! Jan Witowski will be presenting the results from our Ataraxis Breast clinical validation study--stop by to learn how our multi-modal AI and foundation models help personalize breast cancer treatment.

🏆 Ataraxis won 1st place at the Nebius AI Discovery Awards! Out of 250+ global contenders innovating at the intersection of AI and life sciences, our team was honored to receive the top prize in the biotech category — and a $100,000 award — at the Nebius AI Discovery 2025